3-(2-aminoethyl)-5-(4-nitrobenzylidene)thiazolidine-2,4-dione

ID: ALA576895

Cas Number: 726152-87-0

PubChem CID: 2384353

Max Phase: Preclinical

Molecular Formula: C12H11N3O4S

Molecular Weight: 293.30

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  NCCN1C(=O)S/C(=C\c2ccc([N+](=O)[O-])cc2)C1=O

Standard InChI:  InChI=1S/C12H11N3O4S/c13-5-6-14-11(16)10(20-12(14)17)7-8-1-3-9(4-2-8)15(18)19/h1-4,7H,5-6,13H2/b10-7-

Standard InChI Key:  DGFKDNXGDXZIMP-YFHOEESVSA-N

Molfile:  

     RDKit          2D

 20 21  0  0  0  0  0  0  0  0999 V2000
   11.8557   -6.5951    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.8545   -7.4225    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.5694   -7.8352    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.2857   -7.4220    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.2828   -6.5915    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.5676   -6.1824    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.9957   -6.1764    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.7122   -6.5859    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.9586   -7.3725    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   15.7835   -7.3805    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.0467   -6.5979    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   15.3833   -6.1072    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.2619   -8.0526    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   15.3909   -5.2824    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   16.7628   -6.1886    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.4755   -6.6041    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.1916   -6.1947    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   11.1379   -7.8381    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   11.1373   -8.6630    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   10.4239   -7.4251    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  2  3  1  0
  5  6  2  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12  8  1  0
  6  1  1  0
 10 13  2  0
  1  2  2  0
 12 14  2  0
  5  7  1  0
 11 15  1  0
  3  4  2  0
 15 16  1  0
  7  8  2  0
 16 17  1  0
  8  9  1  0
  4  5  1  0
 18 19  2  0
 18 20  1  0
  2 18  1  0
M  CHG  2  18   1  20  -1
M  END

Associated Targets(Human)

RPS6KA1 Tchem Ribosomal protein S6 kinase alpha 1 (2796 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 293.30Molecular Weight (Monoisotopic): 293.0470AlogP: 1.59#Rotatable Bonds: 4
Polar Surface Area: 106.54Molecular Species: BASEHBA: 6HBD: 1
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 9.14CX LogP: 1.22CX LogD: -0.51
Aromatic Rings: 1Heavy Atoms: 20QED Weighted: 0.51Np Likeness Score: -1.81

References

1. Li Q, Al-Ayoubi A, Guo T, Zheng H, Sarkar A, Nguyen T, Eblen ST, Grant S, Kellogg GE, Zhang S..  (2009)  Structure-activity relationship (SAR) studies of 3-(2-amino-ethyl)-5-(4-ethoxy-benzylidene)-thiazolidine-2,4-dione: development of potential substrate-specific ERK1/2 inhibitors.,  19  (21): [PMID:19796943] [10.1016/j.bmcl.2009.09.057]

Source